We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$19.7M
Cap. Flow
-$2.22M
Cap. Flow %
-1.07%
Top 10 Hldgs %
43.03%
Holding
83
New
21
Increased
16
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$6.62M
2
SHPG
Shire pic
SHPG
+$4.24M
3
SNY icon
Sanofi
SNY
+$4.12M
4
CELG
Celgene Corp
CELG
+$3.69M
5
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$2.4M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.25M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.3M
3
ABBV icon
AbbVie
ABBV
+$3.15M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.71M
5
DXCM icon
DexCom
DXCM
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 70.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPXL
26
DELISTED
Impax Laboratories, Inc.
IPXL
$3.17M 1.53%
100,000
+50,000
+100% +$1.46M
IPXL
27
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
$3.17M 1.53%
+100,000
New +$2.93M
WMGI
28
DELISTED
Wright Medical Group Inc
WMGI
$3.09M 1.49%
115,000
+30,000
+35% +$878K
CMRX
29
DELISTED
Chimerix, Inc.
CMRX
$3.02M 1.46%
75,000
– –
ALKS icon
30
Alkermes
ALKS
$8.26B
$2.93M 1.42%
50,000
-10,000
-17% -$509K
NVDQ
31
DELISTED
Novadaq Technologies Inc.
NVDQ
$2.91M 1.41%
175,000
+50,000
+40% +$714K
ZBH icon
32
Zimmer Biomet
ZBH
$18.5B
$2.84M 1.37%
25,750
-25,750
-50% -$2.71M
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.58M 1.25%
200,000
-20,000
-9% -$250K
DYAX
34
DELISTED
DYAX CORPORATION
DYAX
$2.46M 1.19%
175,000
-10,000
-5% -$125K
PFE icon
35
Pfizer
PFE
$152B
$2.34M 1.13%
+79,050
New +$2.27M
RARE icon
36
Ultragenyx Pharmaceutical
RARE
$2.66B
$2.19M 1.06%
50,000
-7,500
-13% -$344K
QDEL icon
37
QuidelOrtho
QDEL
$959M
$2.17M 1.05%
+75,000
New +$2.03M
OSUR icon
38
OraSure Technologies
OSUR
$268M
$2.03M 0.98%
200,000
+25,000
+14% +$224K
PBYI icon
39
Puma Biotechnology
PBYI
$453M
$1.89M 0.91%
10,000
– –
CLDX icon
40
Celldex Therapeutics
CLDX
$3.48B
$1.82M 0.88%
6,667
-3,333
-33% -$829K
MDT icon
41
CALL
Medtronic
MDT
$116B
$1.8M 0.87%
+25,000
New +$1.74M
SPNC
42
DELISTED
Spectranetics Corp
SPNC
$1.73M 0.84%
50,000
-65,000
-57% -$2.03M
ELOS
43
DELISTED
Syneron Medical Ltd
ELOS
$1.63M 0.79%
175,000
+55,000
+46% +$530K
ACHN
44
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$1.53M 0.74%
+125,000
New +$1.53M
FLXN
45
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.51M 0.73%
75,000
+25,000
+50% +$453K
RAD
46
DELISTED
Rite Aid Corporation
RAD
$1.5M 0.73%
+10,000
New +$1.11M
CBAY
47
DELISTED
Cymabay Therapeutics
CBAY
$1.23M 0.59%
125,000
– –
LITS
48
Lite Strategy Inc
LITS
$30.7M
$1.07M 0.52%
+12,500
New +$1.65M
XLRN
49
CALL
DELISTED
Acceleron Pharma
XLRN
$974K 0.47%
+25,000
New +$871K
AXDX
50
DELISTED
Accelerate Diagnostics
AXDX
$960K 0.46%
+5,000
New +$1.07M
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2014 Portfolio in Review

As of Q4 2014, Iguana Healthcare Management held 83 positions worth $207M, up 11% from $187M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management's Q4 2014 filing shows 21 new, 16 increased, 17 reduced and 24 closed positions. Its largest new stake was Shire pic: 20,000 shares worth $4.25M. The largest sale was Amgen, an estimated $7.25M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 71% a quarter earlier.

  • Iguana Healthcare Management's largest Q4 2014 buy was Shire pic: 20,000 shares worth $4.25M.
  • Iguana Healthcare Management added most to Acceleron Pharma in Q4 2014, an estimated $6.62M increase.
  • Iguana Healthcare Management's biggest Q4 2014 reduction was Amgen, cutting an estimated $7.25M.
  • Iguana Healthcare Management fully exited Ionis Pharmaceuticals in Q4 2014, selling an estimated $3.3M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $207M portfolio in Q4 2014.
  • Iguana Healthcare Management opened 21 new positions and closed 24 in Q4 2014.
  • Iguana Healthcare Management's portfolio value rose 11% quarter-over-quarter to $207M.

Based on Iguana Healthcare Management's 13F filing for Q4 2014, filed 18 Feb 2015.